Skip to main content
Log in

Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The blood chemistry and clinical pharmacokinetics of thioridazine and its metabolites, side-chain sulphoxide, side-chain sulphone and ring sulphoxide, were studied in 31 alcoholics and were compared with values in 17 thioridazine-treated controls without alcoholism. Pathological blood chemistry values, including abnormal liver function and protein concentrations, were common among the alcoholics. In relation to dosage, the majority had a low serum concentration of thioridazine and at a given concentration of thioridazine they had high serum concentrations of its metabolites. Positive intercorrelations were found between pathological liver function tests, prolonged serum half-life and increased serum concentration of thioridazine. The free fractions of thioridazine, side-chain sulphoxide and ring sulphoxide were significantly higher and those of the side-chain sulphone lower in the alcoholics than in the controls. The free fractions of side-chain and ring sulphoxide were significantly increased in patients with a low concentration of α1-acid glycoprotein.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Axelsson R, Mårtensson E (1976) Serum concentration and elimination from serum of thioridazine in psychiatric patients. Curr Ther Res 19: 242–265

    Google Scholar 

  2. Spitzer RL (1980) Diagnostic and statistical manual of mental disorders. 3rd ed. (DSM III). American Psychiatric Association, New York

    Google Scholar 

  3. Mårtensson E, Nyberg G, Axelsson R (1975) Quantitative determination of thioridazine and nonconjugated thioridazine metabolites in serum and urine of psychiatric patients. Curr Ther Res 18: 687–700

    Google Scholar 

  4. Nyberg G, Axelsson R, Mårtensson E (1978) Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients. Eur J Clin Pharmacol 14: 341–350

    Google Scholar 

  5. Bradley JV (1968) Distribution-free statistical tests. Prentice-Hall, London

    Google Scholar 

  6. Mantel N (1963) Chi-square test with one degree of freedom; extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 58: 690–695

    Google Scholar 

  7. Odén A, Wedel H (1975) Arguments for Fisher's permutation test. Ann Stat 3: 518–522

    Google Scholar 

  8. Axelsson R, Mårtensson E (1977) The concentration pattern of nonconjugated thioridazine metabolites in serum by thioridazine treatment and its relationship to physiological and clinical variables. Curr Ther Res 21: 561–586

    Google Scholar 

  9. Piafsky K, Borgå O (1977) Plasma protein binding of basic drugs (II). Importance of α1-acid glycoprotein for interindividual variation. Clin Pharmacol Ther 22: 545–549

    Google Scholar 

  10. Axelsson R, Mårtensson E (1980) Side effects of thioridazine and their relationship with the serum concentrations of the drug and its main metabolites. Curr Ther Res 28: 463–489

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Axelsson, R., Mårtensson, E. & Alling, C. Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism. Eur J Clin Pharmacol 23, 359–363 (1982). https://doi.org/10.1007/BF00613621

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00613621

Key words

Navigation